Avita Medical | 1811094D - Ebit

株価
1.14
毎日の変更
0.05 4.61%
毎月
-12.02%
毎年
-55.84%
Q2 予測
1.05


金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 142.87M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


Ebit 変化する 日付
Accuray USD 11.38M 12.71M 2024-09
Celltrion KRW 301.04B 58.57B 2025-09
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Mayne Pharma AUD -16.2M 13.2M 2024-06
Medical Developments International AUD -36K 12.96M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pacific Edge NZD -19.4M 2.91M 2025-12
Paradigm Biopharmaceuticals AUD -21.57M 11.26M 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09